Related Experiment Videos
Moderately severe chronic airflow obstruction. Can corticosteroids slow down obstruction?
D S Postma1, I Peters, E J Steenhuis
1Department of Pulmonology, University Hospital, Groningen, The Netherlands.
The European Respiratory Journal
|January 1, 1988
Summary
Long-term oral corticosteroids, like prednisolone, can slow the progression of chronic airflow obstruction (CAO) in patients with less severe disease. Maintaining a dose of at least 10 mg/day helps stabilize or improve lung function (FEV1).
Area of Science:
- Pulmonology
- Pharmacology
- Respiratory Medicine
Background:
- Previous research suggested oral corticosteroids might slow chronic airflow obstruction (CAO) progression in severe cases.
- This study investigated the long-term effects in patients with less severe CAO.
Purpose of the Study:
- To confirm and extend findings on oral corticosteroid use in chronic airflow obstruction (CAO).
- To analyze long-term disease progression patterns and their association with prednisolone treatment.
Main Methods:
- A 14-20 year longitudinal study of 139 non-allergic patients with less severe CAO.
- Analysis of four distinct patterns of forced expiratory volume in one second (FEV1) and vital capacity (VC) over time.
- Correlation of these patterns with functional residual capacity (FRC%TLC), work of breathing, and prednisolone dosage.
Main Results:
- Four distinct patterns of lung function decline (FEV1, VC) were identified.
- Patients on continuous prednisolone (≥10 mg/day) showed stabilized or improved FEV1.
- Reduced prednisolone dosage (<10 mg/day) correlated with decreased FEV1.
Conclusions:
- Long-term oral prednisolone use is strongly associated with disease course in less severe CAO.
- Maintaining adequate prednisolone dosage is crucial for preserving lung function and slowing disease progression.